PHASE I CLINICAL TRIAL WITH A NOVEL HCV THERAPEUTIC VACCINE TG4040: INTERIM RESULTS OF BIOMARKER AND IMMUNOMONITORING ANALYZES

HEPATOLOGY(2009)

引用 0|浏览13
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要